Core Viewpoint - 康宁杰瑞制药-B (09966) shares increased by over 7%, currently trading at 14.63 HKD with a transaction volume of 37.113 million HKD, following the announcement of a share buyback program [1] Group 1: Share Buyback Announcement - 康宁杰瑞制药 announced a share buyback of 400,000 shares for a total cost of 5.483 million HKD [1] - The company has a maximum buyback limit of 20 million HKD, authorized by the board based on a general mandate approved by shareholders at the annual general meeting on June 12, 2025 [1] Group 2: Upcoming Events - The European Society for Medical Oncology (ESMO) will take place from October 17 to 21 in Berlin, Germany, where the latest research abstracts will be presented [1] - A total of 23 studies from China, including key research on 康宁杰瑞's KN026, have been selected for presentation at the ESMO [1]
康宁杰瑞制药-B涨超7% 此前宣布拟进行场内股份购回 市场关注ESMO大会重磅数据